Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq
Other stock markets
 21:00:00 30/04/2024 BST 		5-day change 1st Jan Change
25.11 USD -1.76% Intraday chart for Protagonist Therapeutics, Inc. -6.48% +9.51%
04-03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT
03-26 Protagonist Therapeutics, Inc. Provides Update on Verify Patient Enrollment and Timing of Top-Line Data CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROTAGONIST THERAPEUTICS, INC. Stock Protagonist Therapeutics, Inc.
 1.5B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.86B
MODERNA, INC. Stock Moderna, Inc.
 42.74B -
LONZA GROUP AG Stock Lonza Group AG
 41.36B
CELLTRION, INC. Stock Celltrion, Inc.
 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 25.15B
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Charts Protagonist Therapeutics, Inc.
  5. Sector Chart